Accounting for Restart Rates in Evaluating Persistence with Ocular Hypotensives
Authors:
- Gail F. SchwartzGSGail F. Schwartz
- Robert PlattRPRobert Platt
- Gregory ReardonGRGregory Reardon
- Marko A. MychaskiwMMMarko A. Mychaskiw
- 1 April 2007
- journal article
- Published by Elsevier in Ophthalmology
- Vol. 114 (4) , 648-652
Abstract
No abstract availableKeywords
Funding Information
- Pfizer
This publication has 10 references indexed in Scilit:
- Compliance et persistanceJournal Français d'Ophtalmologie, 2006
- Measurement of Persistence and Adherence to Regimens of IOP-Lowering Glaucoma Medications Using Pharmacy Claims DataAmerican Journal of Ophthalmology, 2006
- Persistence and Adherence With Topical Glaucoma TherapyAmerican Journal of Ophthalmology, 2005
- Intraocular pressure control and persistence on treatment in glaucoma and ocular hypertensionCanadian Journal of Ophthalmology, 2005
- Patient persistency with topical ocular hypotensive therapy in a managed care populationAmerican Journal of Ophthalmology, 2004
- Persistency with latanoprost or timolol in primary open-angle glaucoma suspectsAmerican Journal of Ophthalmology, 2004
- Observed time between prescription refills for newer ocular hypotensive agents: the effect of bottle sizeAmerican Journal of Ophthalmology, 2004
- Patient Persistency with Pharmacotherapy in the Management of GlaucomaEuropean Journal of Ophthalmology, 2003
- Patient Persistency with ocular prostaglandin therapy: A population-based, retrospective studyClinical Therapeutics, 2003
- Risk factors for noncompliance with glaucoma follow-up visits in a residents’ eye clinicOphthalmology, 1998